Axon wins ALK-Abelló global deal

Axon Communications has emerged triumphant in the battle to secure the contract to handle comms surrounding the development of a yet-to-launch grass pollen allergy tablet for ALK-Abelló.

Richmond-based Axon beat at least two other agencies to secure the account (PRWeek, 23 April), which sees the agency handling PR, medical education and ‘clinical research consulting’ for the Danish allergy vaccine giant.

Axon managing partner Ralph Sutton described his agency’s remit as ‘strategic’, adding that details of the campaign were still being thrashed out.

The product is yet to have a brand name and is undergoing clinical trials. The agency’s contract, which is understood to be potentially worth an annual budget of around £200,000, sees the agency report to ALK staff, including international marketing manager Ulf Blom.

Axon’s programme will be global with a focus on Europe. Axon is a subsidiary of Canadian comms giant National Public Relations.

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus

Latest Articles

Max Clifford trial jury to continue deliberations tomorrow

Max Clifford trial jury to continue deliberations tomorrow

The jury in the trial of celebrity publicist Max Clifford has been sent home after a second day of deliberations about its verdicts on 11 charges of indecent assault.

Champagne producer Charles Heidsieck appoints Story PR